NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Katie Maass
AD Scientific Index 2024
Others
Genentech, Inc - South San Francisco / United States
-
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Katie Maass's MOST POPULAR ARTICLES
1-)
The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized Phase 2 ladder clinical trialPA Campochiaro, DM Marcus, CC Awh, C Regillo, AP Adamis, ...Ophthalmology 126 (8), 1141-1154, 20192172019
2-)
Archway randomized phase 3 trial of the port delivery system with Ranibizumab for neovascular age-related macular degenerationNM Holekamp, PA Campochiaro, MA Chang, D Miller, D Pieramici, ...Ophthalmology 129 (3), 295-307, 2022632022
3-)
Determination of cellular processing rates for a trastuzumab-maytansinoid antibody-drug conjugate (ADC) highlights key parameters for ADC designKF Maass, C Kulkarni, AM Betts, KD WittrupThe AAPS journal 18 (3), 635-646, 2016562016
4-)
Evolution of antibody-drug conjugate tumor disposition model to predict preclinical tumor pharmacokinetics of trastuzumab-emtansine (T-DM1)AP Singh, KF Maass, AM Betts, KD Wittrup, C Kulkarni, LE King, A Khot, ...The AAPS journal 18, 861-875, 2016462016
5-)
Ocular half-life of intravitreal biologics in humans and other species: meta-analysis and model-based predictionA Caruso, M Füth, R Alvarez-Sánchez, S Belli, C Diack, KF Maass, ...Molecular pharmaceutics 17 (2), 695-709, 2019452019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept